These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 15248293

  • 21. Ribavirin reduces clinical signs and pathological changes of experimental autoimmune encephalomyelitis in Dark Agouti rats.
    Milicevic I, Pekovic S, Subasic S, Mostarica-Stojkovic M, Stosic-Grujicic S, Medic-Mijacevic L, Pejanovic V, Rakic L, Stojiljkovic M.
    J Neurosci Res; 2003 Apr 15; 72(2):268-78. PubMed ID: 12672002
    [Abstract] [Full Text] [Related]

  • 22. Delayed, relapsing experimental allergic encephalomyelitis in mice.
    Lublin FD, Maurer PH, Berry RG, Tippett D.
    J Immunol; 1981 Mar 15; 126(3):819-22. PubMed ID: 7462632
    [Abstract] [Full Text] [Related]

  • 23. Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.
    Forte M, Gold BG, Marracci G, Chaudhary P, Basso E, Johnsen D, Yu X, Fowlkes J, Rahder M, Stem K, Bernardi P, Bourdette D.
    Proc Natl Acad Sci U S A; 2007 May 01; 104(18):7558-63. PubMed ID: 17463082
    [Abstract] [Full Text] [Related]

  • 24. Anterior uveitis in murine relapsing experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS).
    Constantinescu CS, Lavi E.
    Curr Eye Res; 2000 Jan 01; 20(1):71-6. PubMed ID: 10611718
    [Abstract] [Full Text] [Related]

  • 25. Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis.
    Li FQ, Sempowski GD, McKenna SE, Laskowitz DT, Colton CA, Vitek MP.
    J Pharmacol Exp Ther; 2006 Sep 01; 318(3):956-65. PubMed ID: 16740622
    [Abstract] [Full Text] [Related]

  • 26. Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss.
    Butzkueven H, Emery B, Cipriani T, Marriott MP, Kilpatrick TJ.
    Glia; 2006 May 01; 53(7):696-703. PubMed ID: 16498619
    [Abstract] [Full Text] [Related]

  • 27. Functional and molecular evidence of myelin- and neuroprotection by thyroid hormone administration in experimental allergic encephalomyelitis.
    Dell'Acqua ML, Lorenzini L, D'Intino G, Sivilia S, Pasqualetti P, Panetta V, Paradisi M, Filippi MM, Baiguera C, Pizzi M, Giardino L, Rossini PM, Calzà L.
    Neuropathol Appl Neurobiol; 2012 Aug 01; 38(5):454-70. PubMed ID: 22007951
    [Abstract] [Full Text] [Related]

  • 28. Nerve growth factor prevents demyelination, cell death and progression of the disease in experimental allergic encephalomyelitis.
    Parvaneh Tafreshi A.
    Iran J Allergy Asthma Immunol; 2006 Dec 01; 5(4):177-81. PubMed ID: 17237570
    [Abstract] [Full Text] [Related]

  • 29. Improved clinical behavior of established relapsing-remitting experimental autoimmune encephalomyelitis following treatment with endogenous opioids: implications for the treatment of multiple sclerosis.
    Hammer LA, Zagon IS, McLaughlin PJ.
    Brain Res Bull; 2015 Mar 01; 112():42-51. PubMed ID: 25647234
    [Abstract] [Full Text] [Related]

  • 30. Glutamate excitotoxicity in a model of multiple sclerosis.
    Pitt D, Werner P, Raine CS.
    Nat Med; 2000 Jan 01; 6(1):67-70. PubMed ID: 10613826
    [Abstract] [Full Text] [Related]

  • 31. Chronologic neuropathology of relapsing experimental allergic encephalomyelitis in the mouse.
    Brown A, McFarlin DE, Raine CS.
    Lab Invest; 1982 Feb 01; 46(2):171-85. PubMed ID: 7062721
    [Abstract] [Full Text] [Related]

  • 32. The immunosuppressant FK506 elicits a neuronal heat shock response and protects against acrylamide neuropathy.
    Gold BG, Voda J, Yu X, Gordon H.
    Exp Neurol; 2004 May 01; 187(1):160-70. PubMed ID: 15081597
    [Abstract] [Full Text] [Related]

  • 33. High resolution diffusion tensor imaging of axonal damage in focal inflammatory and demyelinating lesions in rat spinal cord.
    DeBoy CA, Zhang J, Dike S, Shats I, Jones M, Reich DS, Mori S, Nguyen T, Rothstein B, Miller RH, Griffin JT, Kerr DA, Calabresi PA.
    Brain; 2007 Aug 01; 130(Pt 8):2199-210. PubMed ID: 17557778
    [Abstract] [Full Text] [Related]

  • 34. Increased thrombin inhibition in experimental autoimmune encephalomyelitis.
    Beilin O, Karussis DM, Korczyn AD, Gurwitz D, Aronovich R, Hantai D, Grigoriadis N, Mizrachi-Kol R, Chapman J.
    J Neurosci Res; 2005 Feb 01; 79(3):351-9. PubMed ID: 15605378
    [Abstract] [Full Text] [Related]

  • 35. Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multiple sclerosis.
    Zagon IS, Rahn KA, Turel AP, McLaughlin PJ.
    Exp Biol Med (Maywood); 2009 Nov 01; 234(11):1383-92. PubMed ID: 19855075
    [Abstract] [Full Text] [Related]

  • 36. Transplanted neural precursor cells reduce brain inflammation to attenuate chronic experimental autoimmune encephalomyelitis.
    Einstein O, Grigoriadis N, Mizrachi-Kol R, Reinhartz E, Polyzoidou E, Lavon I, Milonas I, Karussis D, Abramsky O, Ben-Hur T.
    Exp Neurol; 2006 Apr 01; 198(2):275-84. PubMed ID: 16472805
    [Abstract] [Full Text] [Related]

  • 37. Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis.
    Diem R, Sättler MB, Merkler D, Demmer I, Maier K, Stadelmann C, Ehrenreich H, Bähr M.
    Brain; 2005 Feb 01; 128(Pt 2):375-85. PubMed ID: 15601662
    [Abstract] [Full Text] [Related]

  • 38. Phenytoin protects central axons in experimental autoimmune encephalomyelitis.
    Black JA, Waxman SG.
    J Neurol Sci; 2008 Nov 15; 274(1-2):57-63. PubMed ID: 18485368
    [Abstract] [Full Text] [Related]

  • 39. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.
    Kornek B, Storch MK, Weissert R, Wallstroem E, Stefferl A, Olsson T, Linington C, Schmidbauer M, Lassmann H.
    Am J Pathol; 2000 Jul 15; 157(1):267-76. PubMed ID: 10880396
    [Abstract] [Full Text] [Related]

  • 40. Administration of a monomeric CCL2 variant to EAE mice inhibits inflammatory cell recruitment and protects from demyelination and axonal loss.
    Brini E, Ruffini F, Bergami A, Brambilla E, Dati G, Greco B, Cirillo R, Proudfoot AE, Comi G, Furlan R, Zaratin P, Martino G.
    J Neuroimmunol; 2009 Apr 30; 209(1-2):33-9. PubMed ID: 19232440
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.